Related Articles
Pathological complete response following cisplatin or carboplatin‑based neoadjuvant chemotherapy for triple‑negative breast cancer: A systematic review and meta‑analysis
Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?
Strong impact of pathological node‑negative on long‑term overall survival of patients with triple‑negative breast cancer receiving neoadjuvant chemotherapy
Cyclooxygenase‑2 expression in non‑metastatic triple‑negative breast cancer patients
Effect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis